• Molecular NameCyclobarbital
  • SynonymNA
  • Weight236.271
  • Drugbank_IDN/A
  • ACS_NO52-31-3
  • Show 3D model
  • LogP (experiment)1.77
  • LogP (predicted, AB/LogP v2.0)1.74
  • pka7.6
  • LogD (pH=7, predicted)1.69
  • Solubility (experiment)2.26 mg/ml
  • LogS (predicted, ACD/Labs)(ph=7)-2.55
  • LogSw (predicted, AB/LogsW2.0)0.85
  • Sw (mg/ml) (predicted, ACD/Labs)0.61
  • No.of HBond Donors2
  • No.of HBond Acceptors5
  • No.of Rotatable Bonds2
  • TPSA75.27
  • StatusN/A
  • AdministrationN/A
  • PharmacologyA drug which is a barbiturate derivative.
  • Absorption_valueN/A
  • Absorption (description)Rapidly absorbed after oral administration.
  • Caco_2N/A
  • BioavailabilityN/A
  • Protein binding70.0
  • Volume of distribution (VD)0.5 L/kg
  • Blood/Plasma Partitioning ratio (D_blood)N/A
  • MetabollsmThe main metabolic reaction appears to be oxidation to ketocyclobarbital [5-(3-oxocyclohex-1-enyl)-5-ethylbarbituric acid].
  • Half life12 h
  • ExcretionLess than 10% of a dose is excreted in the urine unchanged.
  • Urinary ExcretionN/A
  • Clerance0.5 ml/min/kg
  • ToxicityThe estimated minimum lethal dose is 2 g. Severe toxic effects are associated with blood concentrations greater than 10 mg/L.
  • LD50 (rat)N/A
  • LD50 (mouse)N/A